4.7 Review

cAMP signalling in insulin and glucagon secretion

期刊

DIABETES OBESITY & METABOLISM
卷 19, 期 -, 页码 42-53

出版社

WILEY
DOI: 10.1111/dom.12993

关键词

beta-cell; glucagon; incretins; insulin secretion; islets; type 2 diabetes

资金

  1. Diabetes Wellness Foundation
  2. European Foundation for the Study of Diabetes (EFSD-MSD)
  3. Family Ernfors foundation
  4. Novo Nordisk Foundation
  5. Swedish Diabetes Foundation
  6. Swedish Research Council [2012-6778]
  7. Excellence of Diabetes Research in Sweden, EXODIAB
  8. European Foundation for the Study of Diabetes [MSD 2014_2, NN 2017_5] Funding Source: researchfish
  9. Novo Nordisk Fonden [NNF14OC0010363] Funding Source: researchfish

向作者/读者索取更多资源

The second messenger archetype cAMP is one of the most important cellular signalling molecules with central functions including the regulation of insulin and glucagon secretion from the pancreatic - and -cells, respectively. cAMP is generally considered as an amplifier of insulin secretion triggered by Ca2+ elevation in the -cells. Both messengers are also positive modulators of glucagon release from -cells, but in this case cAMP may be the important regulator and Ca2+ have a more permissive role. The actions of cAMP are mediated by protein kinase A (PKA) and the guanine nucleotide exchange factor Epac. The present review focuses on how cAMP is regulated by nutrients, hormones and neural factors in - and -cells via adenylyl cyclase-catalysed generation and phosphodiesterase-mediated degradation. We will also discuss how PKA and Epac affect ion fluxes and the secretory machinery to transduce the stimulatory effects on insulin and glucagon secretion. Finally, we will briefly describe disturbances of the cAMP system associated with diabetes and how cAMP signalling can be targeted to normalize hypo- and hypersecretion of insulin and glucagon, respectively, in diabetic patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据